See also this year's filing and all EDGAR filings for this company.
PDF Report 0001307969_2012_024_Pharma_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001307969, 024 Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 1,273,425 |
| 1 | LiabilitiesNoncurrent | 0 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 1,187,285 |
| 4 | PropertyPlantAndEquipmentNet | 10,090 |
| 5 | IntangibleAssets | 52,657 |
| 6 | AssetsNoncurrent | 0 |
| 7 | remainder_Assets | 0 |
| 8 | CostOfRevenue | 63,755 |
| 9 | SellingGeneralAndAdministrativeExpense | 655,678 |
| 10 | remainder_Expenses | 19,582 |
| 11 | remainder_Revenues | 266,307 |
| 12 | remainder_NetIncome | 341,381 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 1,273,425 |
| 1 | Assets | 1,250,032 |
| 2 | Expenses | 739,015 |
| 3 | Revenues | 266,307 |
| 4 | StockholdersEquity | -23,393 |
| 5 | NetIncome | -131,327 |
| 6 | ComprehensiveNetIncome | -131,327 |
| 7 | BaseVar | 1,935,080 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.119 |
| 9 | EconomicCapitalRatio | 0.736 |
Edgar->Model Mapping
Feature Distribution
